Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
01 1Egis Pharmaceuticals PLC
02 1EUROAPI
03 1Minakem (formerly Delmar Chemicals)
04 1Sanofi
05 1Biophore India Pharmaceuticals Pvt Ltd
06 1LGM Pharma
07 1Jai Radhe Sales
08 1HRV Global Life Sciences
09 1ACIC Europe API & Pharmaceuticals
10 1American Chemical Products
11 1Anphar Laboratories
12 2Chromo Laboratories
13 1Cyclo Therapeutics
14 1Dasami Lab
15 1Dolder AG
16 1Emcure Pharmaceuticals
17 1Enaltec Labs Private Limited
18 1Guangzhou Tosun Pharmaceutical
19 1Gyma Laboratories of America
20 1Hetero Drugs
21 1Kalintis Healthcare
22 1Lonza Inc & Lonza America Inc
23 1Lycored
24 1Maithili Life Sciences
25 1Maithri Drugs
26 1Meck Pharma
27 1Nishchem International Pvt. Ltd
28 3R L Fine Chem
29 1Raks Pharma
30 1SKVen Technologies Pvt. Ltd
31 1Solara Active Pharma Sciences
32 1Synergene Active Ingredients Pvt Ltd
33 2Taro Pharmaceutical Industries
34 1Trifarma
35 4Blank
01 1Canada
02 1China
03 1Cyprus
04 2France
05 1Hungary
06 22India
07 1Italy
08 1Switzerland
09 8U.S.A
10 4Blank
01 9Active
02 13Inactive
03 20Blank
01 5Valid
02 37Blank
01 1219MF10261
02 1222MF10096
03 1304MF10157
04 39Blank
01 1WC-0139
02 1WC-0317
03 1WC-0317A2
04 1WC-0424
05 1WC-0445A2
06 1WC-0445A3
07 1WC-0455
08 1WC-0511
09 1WC-0578
10 1WC-258
11 32Blank
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 1996-077 - Rev 07
Issue Date : 2021-10-15
Type : Chemical
Substance Number : 475
Status : Valid
Registration Number : 304MF10157
Registrant's Address : H-1106 BUDAPEST KERESZTURI UT 30-38 HUNGARY
Initial Date of Registration : 2022-12-15
Latest Date of Registration :
Available Reg Filing : ASMF, BR |
Registration Number : 222MF10096
Registrant's Address : 82 Avenue Raspail 94250 Gentilly France
Initial Date of Registration : 2010-03-17
Latest Date of Registration :
NDC Package Code : 82298-901
Start Marketing Date : 2011-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-03
Pay. Date : 2013-02-13
DMF Number : 1516
Submission : 1970-04-23
Status : Active
Type : II
Certificate Number : CEP 1999-043 - Rev 08
Issue Date : 2024-02-16
Type : Chemical
Substance Number : 475
Status : Valid
NDC Package Code : 50396-7515
Start Marketing Date : 2011-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-07-05
Pay. Date : 2017-06-19
DMF Number : 31479
Submission : 2017-06-17
Status : Active
Type : II
Certificate Number : R0-CEP 2021-266 - Rev 00
Issue Date : 2023-03-08
Type : Chemical
Substance Number : 475
Status : Valid
Date of Issue : 2021-10-22
Valid Till : 2024-10-21
Written Confirmation Number : WC-0511
Address of the Firm :
NDC Package Code : 73435-001
Start Marketing Date : 2019-11-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-07-02
Pay. Date : 2020-06-09
DMF Number : 33554
Submission : 2019-02-20
Status : Active
Type : II
NDC Package Code : 72643-033
Start Marketing Date : 2023-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-11-06
Pay. Date : 2020-09-28
DMF Number : 35189
Submission : 2020-09-29
Status : Active
Type : II
Date of Issue : 2024-02-19
Valid Till : 2027-02-19
Written Confirmation Number : WC-0578
Address of the Firm :
NDC Package Code : 70966-0017
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-06-22
Pay. Date : 2018-05-15
DMF Number : 32014
Submission : 2018-05-25
Status : Active
Type : II
Date of Issue : 2018-12-03
Valid Till : 2021-07-09
Written Confirmation Number : WC-0424
Address of the Firm :
NDC Package Code : 42413-0137
Start Marketing Date : 2018-05-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-08-14
Pay. Date : 2018-06-20
DMF Number : 32920
Submission : 2018-07-09
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-07-09
Pay. Date : 2018-11-15
DMF Number : 30731
Submission : 2017-04-11
Status : Active
Type : II
Certificate Number : CEP 2018-009 - Rev 03
Issue Date : 2024-06-19
Type : Chemical
Substance Number : 475
Status : Valid
Date of Issue : 2020-03-31
Valid Till : 2022-07-28
Written Confirmation Number : WC-0445A3
Address of the Firm :
NDC Package Code : 71554-002
Start Marketing Date : 2019-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34248
Submission : 2019-12-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3058
Submission : 1977-11-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 469
Submission : 1962-02-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5499
Submission : 1984-07-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4442
Submission : 1982-02-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2135
Submission : 1973-07-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2860
Submission : 1977-02-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2270
Submission : 1974-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1730
Submission : 1971-05-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1741
Submission : 1971-06-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1616
Submission : 1970-07-02
Status : Inactive
Type : II
Certificate Number : R0-CEP 2021-018 - Rev 02
Issue Date : 2023-02-15
Type : Chemical
Substance Number : 475
Status : Valid
Date of Issue : 2020-03-31
Valid Till : 2022-07-28
Written Confirmation Number : WC-0445A2
Address of the Firm :
NDC Package Code : 71554-002
Start Marketing Date : 2019-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-02-02
Valid Till : 2024-06-07
Written Confirmation Number : WC-0317
Address of the Firm :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 913
Submission : 1965-09-07
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1943
Submission : 1972-06-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3547
Submission : 1979-06-06
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Chlorpromazine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorpromazine Hydrochloride, including repackagers and relabelers. The FDA regulates Chlorpromazine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorpromazine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorpromazine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorpromazine Hydrochloride supplier is an individual or a company that provides Chlorpromazine Hydrochloride active pharmaceutical ingredient (API) or Chlorpromazine Hydrochloride finished formulations upon request. The Chlorpromazine Hydrochloride suppliers may include Chlorpromazine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorpromazine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 34 companies offering Chlorpromazine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?